Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Manrique, , Alberto,
DOB: 05-APR-1993 (Age: 32)
Gender: male
Address:
Pasaje de Elisabet Rey 25
47001 Valladolid (Spain)
ID: 7218-581842-3 (ECI)
Report
Date: 26-NOV-2020
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Hospital Recoletas Campo Grande
Calle de la Estación del Norte nan
47007 Valladolid (Spain)
Specimen
Collected: 26-NOV-2020

Chemistry

Test 26-NOV-2020 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 175.7 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 125.3 40 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 86.1 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 64.5 H 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All lipid parameters are within or slightly above the normal range, with HDL cholesterol mildly elevated, which is generally considered protective. No evidence of dyslipidemia or increased cardiovascular risk from these results. No laboratory abnormalities requiring intervention.